摘要
The presence of excessive reactive oxygen species(Ros)at a skin wound site is an important factor affecting wound healing.ROS scavenging,which regulates the ROS microenvironment,is essential for wound healing.In this study,we used novel electrospun PCL/gelatin/arbutin(PCL/G/A)nanofibrous membranes as wound dressings,with PCL/gelatin(PCL/G)as the backbone,and plantderived arbutin(hydroquinone-β-D-glucopyranoside,ARB)as an effective antioxidant that scavenges ROos and inhibits bacterial infection in wounds.The loading of ARB increased the mechanical strength of the nanofibres,with a water vapour transmission rate of more than 2500g/(m^(2)×24h),and the water contact angle decreased,indicating that hydrophilicity and air permeability were significantly improved.Drug release and degradation experiments showed that the nanofibre membrane controlled the drug release and exhibited favourable degradability.Haemolysis experiments showed that the PCL/G/A nanofibre membranes were biocompatible,and DPPH and ABTS+radical scavenging experiments indicated that PCL/G/A could effectively scavenge ROS to reflect the antioxidant activity.In addition,haemostasis experiments showed that PCL/G/A had good haemostatic effects in vitro and in vivo.In vivo animal wound closure and histological staining experiments demonstrated that PCL/G/A increased collagen deposition and remodelled epithelial tissue regeneration while showing good in vivo biocompatibility and non-toxicity.In conclusion,we successfully prepared a multifunctional wound dressing,PCL/G/A,for skin wound healing and investigated its potential role in wound healing,which is beneficial for the clinical translational application of phytomedicines.
基金
the Guangxi Science and Technology Base andTalent Special Project(Grant No.GuikeAD19254003)
Guangxi Scientific Research and Technological Development Foundation(Grant No.GuikeAB21220062)
Guangxi University's young and middle-aged teachers'basic scientific research ability enhancement project(Grant No.2022KY0104)
Open Research Fund From Guangxi Key Laboratory Of Regenerative Medicine,Guangxi Medical University(Grant No.202003)
The Foundation of the Collaborative Innovation Centre of Regenerative Medicine and Medical Bioresource Development and Application Coconstructed by the Province and Ministry(Grant No.CICRMMBRTC-2023001)
‘Medical Excellence Award'Funded By The Creative Research Development Grant From The First Affiliated Hospital of Guangxi Medical University(Grant No.202210)
Guangxi Health Commission self-funded scientific research project(Grant No.Z20180949).